Trex Company, Inc. Investigated by the Portnoy Law Firm
Globenewswire· 2025-11-06 15:57
LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Trex Company, Inc., (“Trex" or the "Company") (NYSE: TREX) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/trex-company-inc. The Portnoy Law Firm can ...
IonQ Q3 Earnings Miss Estimates, Revenues Surge Y/Y, Stock Up
ZACKS· 2025-11-06 15:56
Core Insights - IonQ reported a net loss of $3.58 per share in Q3 2025, significantly wider than the Zacks Consensus Estimate of a loss of 44 cents and above the previous year's loss of 24 cents [1] - Revenues for Q3 reached $39.87 million, representing a 222% year-over-year growth and exceeding the high end of the company's prior guidance by 37%, beating the Zacks Consensus Estimate by 47.57% [1] Financial Performance - The cost of revenues (excluding depreciation and amortization) in Q3 totaled $21.3 million, up 226.2% year-over-year, primarily due to increased labor and materials costs [3] - Sales and marketing costs rose 117.8% to $14.4 million, driven by higher payroll-related expenses and promotional costs [3] - Research and development costs increased by 99.8% year-over-year to $66.3 million, while general and administrative costs surged 476.1% to $82.5 million [4] - IonQ posted an adjusted EBITDA loss of $48.9 million in Q3 [4] Cash Position and Outlook - As of September 30, IonQ had cash, cash equivalents, and investments totaling $1.5 billion, with a pro-forma amount of $3.5 billion following a $2 billion equity offering that closed on October 14, 2025 [5] - Cumulative net cash used in operating activities reached $208.7 million compared to $66.3 million in the same period last year [5] - For the full year 2025, IonQ expects revenues between $106 million and $110 million, up from a previous estimate of $82-$100 million, while reaffirming its adjusted EBITDA loss guidance between ($206) million and ($216) million [6] Strategic Developments - IonQ achieved a milestone algorithmic qubit score of AQ 64 on an IonQ Tempo system, three months ahead of schedule, meeting its technical goal for the year [7] - The company announced a breakthrough in synthetic diamond materials, enhancing quantum networking scale and production [7] - IonQ completed the acquisition of Oxford Ionics, which strengthens its quantum hardware capabilities [9]
How Much Upside is Left in P10 (PX)? Wall Street Analysts Think 46.5%
ZACKS· 2025-11-06 15:56
P10, Inc. (PX) closed the last trading session at $10.58, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.5 indicates a 46.5% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $3.79. While the lowest estimate of $13.00 indicates a 22.9% increase from the current price level, the most optimistic analyst expects t ...
Fresnillo (FNLPF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2025-11-06 15:56
Core Viewpoint - Fresnillo PLC (FNLPF) has experienced a bearish trend, losing 10.2% over the past four weeks, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottom in the stock price, characterized by a small candle body and a long lower wick, suggesting that bears may be losing control [4][5]. - This pattern typically forms during a downtrend when the stock opens lower, makes a new low, but then finds support and closes near its opening price, indicating a possible shift in momentum [4][5]. Fundamental Analysis - There has been a positive trend in earnings estimate revisions for FNLPF, with a 42.6% increase in the consensus EPS estimate for the current year over the last 30 days, indicating that analysts expect better earnings than previously predicted [7][8]. - The company currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks, which typically outperform the market [9][10].
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know
ZACKS· 2025-11-06 15:56
Core Viewpoint - InfuSystems Holdings, Inc. (INFU) has seen a 1.8% increase in share price over the past four weeks, closing at $10, with analysts suggesting a potential upside of 40% based on a mean price target of $14 [1] Price Targets - The average price target consists of five estimates ranging from a low of $12.00 to a high of $15.00, with a standard deviation of $1.41, indicating a potential increase of 20% to 50% from the current price level [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which can be a positive indicator for investors [2][9] Analyst Sentiment - Analysts have shown increasing optimism about INFU's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - The Zacks Consensus Estimate for the current year has risen by 13.7% over the past month, with no negative revisions, indicating a favorable outlook for the company [12] Zacks Rank - INFU holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, further supporting the potential for stock price appreciation [13] Conclusion on Price Movement - While the consensus price target may not be entirely reliable, the direction indicated by the price movement appears to be a useful guide for potential investment decisions [14]
Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
ZACKS· 2025-11-06 15:56
Core Viewpoint - Innate Pharma S.A. (IPHA) has experienced a downtrend, losing 12.1% over the past week, but a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with selling pressure likely subsiding, which could lead to a bullish trend [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, signaling that bears may be losing control [4][5]. - This pattern can occur across various timeframes and is utilized by both short-term and long-term investors [5]. Fundamental Analysis - Recent upward revisions in earnings estimates for IPHA are a bullish indicator, as they correlate strongly with near-term stock price movements [7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 1.5%, indicating analysts expect better earnings than previously predicted [8]. - IPHA holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].
Wall Street Analysts Think Liquidia Corporation (LQDA) Could Surge 62.34%: Read This Before Placing a Bet
ZACKS· 2025-11-06 15:56
Shares of Liquidia Corporation (LQDA) have gained 9.7% over the past four weeks to close the last trading session at $26.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $42.89 indicates a potential upside of 62.3%.The average comprises nine short-term price targets ranging from a low of $6.00 to a high of $67.00, with a standard deviation of $16.92. While the lowest estimate ...
Wall Street Analysts See a 25.29% Upside in Universal Display (OLED): Can the Stock Really Move This High?
ZACKS· 2025-11-06 15:56
Universal Display Corp. (OLED) closed the last trading session at $146.75, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $183.86 indicates a 25.3% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $21.77. While the lowest estimate of $160.00 indicates a 9% increase from the current price level, the most optimisti ...
INmune Bio (INMB) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2025-11-06 15:56
A downtrend has been apparent in INmune Bio, Inc. (INMB) lately. While the stock has lost 11.9% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish ca ...
$12 Billion Fund Chief Says Bitcoin Rally Coming Before Year-End
Yahoo Finance· 2025-11-06 15:55
$12 Billion Bitwise Fund Chief, Matt Hougan, Says Bitcoin Rally Is Coming Before Year-End Speaking in a recent market interview on CNBC, the Bitwise Chief Investment Officer described the current retail environment as one of “maximum desperation,” citing the recent wave of leveraged liquidations, futures wipeouts, and yield protocol failures as evidence. According to him, the market sentiment at the moment is at its most depressive level, which signals a bottom rather than the end of the cycle. “The cry ...